Core Insights - The forum focused on the latest developments in exosome technology and the progress of local cell technology companies in achieving international compliance for related raw materials [1][3][5] Group 1: Event Overview - The forum, themed "Exploring Cell Messengers Leading the Future of Regeneration," was held in Xi'an and co-hosted by the Xi'an Science and Technology Association and the Xi'an High-tech Zone Management Committee [1][3] - It attracted participation from academic experts, government representatives, clinical researchers, and industry professionals, highlighting the application potential of exosomes in regenerative medicine and disease diagnosis [3][5] Group 2: Key Presentations - Renowned scientist Academician Pei Duanqing provided insights into the development trends, scientific value, and future prospects of exosome technology, emphasizing its potential in regenerative medicine, disease diagnosis, and new drug development [5] - He noted that the standardization and industrialization of exosomes are essential directions for the future [5] Group 3: Industry Developments - The forum announced that local company Medcell Biotechnology's exosome raw materials have received FDA DMF (Drug Master File) registration and have been included in the International Cosmetic Ingredient (INCI) list [5] - This FDA DMF registration indicates that the raw materials meet pharmaceutical-grade regulatory standards, facilitating their application in innovative drug development, while inclusion in the INCI list opens opportunities in the cosmetics sector [5] Group 4: Collaborative Efforts - A ceremony for "Building an Innovative Ecosystem for the Exosome Industry" was held, showcasing the collective commitment of academicians, university representatives, and business leaders to advance exosome technology from laboratory research to industrial application [7] - Collaborating institutions include Shaanxi Normal University and Northwestern Polytechnical University, contributing to the promotion of industry-academia-research cooperation in the biopharmaceutical frontier [7]

Core Insights - The Anhui branch of the China Marrow Donor Program has achieved significant results despite being one of the smallest repositories, ranking second in national annual and cumulative capacity utilization and eighth in annual donations, demonstrating the potential of smaller repositories [1][2] - The "随叫髓到" team from Wannan Medical College has developed a unique approach to address the issue of donor withdrawal, focusing on awareness, service empowerment, and value reconstruction, which has led to increased engagement and donations [1][3] Summary by Sections Achievements and Statistics - Since 2016, Anhui Province has shown a unique advantage with an average annual increase of 12.19% in hematopoietic stem cell donations, achieving remarkable speed in emergency donations [2] - The "随叫髓到" team has successfully conducted extensive research, including over 10,000 phone callbacks and 5,216 valid questionnaires, to understand and address donor withdrawal [1][3] Team Initiatives and Strategies - The team has built a communication bridge with volunteers through social practice activities, engaging with various community sectors, including Red Cross societies and universities [3] - They implemented a "Four-Wheel Research Method" to deeply analyze donor intentions and the psychological factors behind withdrawal, leading to a better understanding of the challenges faced by potential donors [3][4] Addressing Donor Withdrawal - The team identified three core contradictions behind donor withdrawal: cognitive bias, service gaps, and value loss, and created detailed profiles of different types of withdrawers to guide their strategies [4] - Innovative educational initiatives, such as the "Five Speakers" presentation matrix and a comprehensive support mechanism for donors, have been established to enhance donor confidence and understanding [4] Results and Future Plans - The team's efforts have resulted in significant increases in donation numbers, with some cities reporting double the number of donors compared to previous years [5] - The team has expanded its outreach efforts, sharing their experiences and strategies with other provinces, and has seen over 300 students register as marrow donors [6]

Core Insights - Rivian's CEO RJ Scaringe emphasizes that traditional automakers will face significant challenges in future market competition if they do not enhance their software development capabilities [1][2] Group 1: Software Development and Market Competition - By the early 2030s, automakers that do not establish a software-driven architecture will struggle to maintain market share in mass production [2] - Many large automakers currently rely on disconnected "software silos," which are incompatible with an AI-driven automotive world [2] - Scaringe warns that failure to adapt will lead to loss of market share, while companies mastering this technology will rapidly expand in the next decade [2] Group 2: Options for Traditional Automakers - Traditional automakers have limited choices: they can either develop software in-house, which is challenging due to a lack of capability, rely on suppliers who may resist losing control, or collaborate with new entrants [2] - Rivian has established its own technology stack and is engaged in a software partnership with Volkswagen worth up to $5.8 billion (approximately 41.38 billion RMB) [2]

来源：环球网 【环球网科技综合报道】10月15日消息，据彭博社报道称，高盛集团（Goldman Sachs Group Inc.）已通 知员工，预计今年将进行新一轮裁员。此次裁员是该银行进一步降低各业务部门成本，并充分利用人工 智能技术带来的机遇的重要举措。 他们还强调："为了充分释放人工智能的潜力，我们必须在运营的各个方面实现更高的速度与敏捷性。 这不仅仅意味着对平台进行重新改造。" 一份周二上午发给员工的备忘录显示，高盛将"控制今年年底前的人员增长"，并计划在全公司范围 内"有限度地削减部分岗位"。尽管如此，高盛发言人詹妮弗・祖卡雷利（Jennifer Zuccarelli）在电话采 访中补充称，公司预计到年底整体员工人数仍将有所增加。截至9月底，高盛的员工总数为48300人，较 去年底增加了约1800人。 在备忘录中，高盛宣布启动其"OneGS 3.0"战略，高层管理人员在信中强调，人工智能带来的效率提升 将成为推动未来增长的重要路径。 高盛首席执行官大卫・所罗门（David Solomon）、总裁约翰・沃尔德伦（John Waldron）以及首席财务 官丹尼斯・科尔曼（Denis Coleman）在备 ...

Core Insights - Apple is expanding its production in Vietnam and plans to launch several new home devices, including a security camera and a central control display device by 2026 [1][3] - The launch of a mobile desktop robot has been delayed to 2027 due to complex design and AI application challenges [1][3] Product Development - Apple plans to release an indoor security camera, codenamed J450, by the end of next year [3] - A new central control device is expected to be priced around $350, which is $50 more than the full-sized HomePod [3] - The new version of Siri is set to launch in March next year, enhancing its capabilities to control home appliances and provide answers from the internet [3] Production Challenges - The release of the central control device has been postponed to spring 2026 due to delays in AI software development [3] - Apple is researching ways to reduce manufacturing costs to potentially lower prices for initial or subsequent models [3] - The development of the desktop robot has been pushed back by approximately two years due to the complexity of its motor system design [3]

Core Insights - The research team led by Academician Liu Xiufan has made significant breakthroughs in understanding the pathogenic mechanism of Newcastle Disease Virus (NDV), as published in the journal PLOS Pathogens [1][2] - The study reveals how NDV utilizes the cytoskeleton to promote its spreading infection, highlighting the molecular mechanisms involved [1][2] Group 1: Research Findings - NDV infection disrupts the expression of tight junction proteins such as OCLN and ZO-1, leading to the breakdown of intercellular tight junction homeostasis, with key roles played by Caspase pathways and viral proteins NP, F, and HN [2] - The research identifies that NDV induces rearrangement of the cytoskeletal protein vimentin and F-actin, forming cage-like structures that enhance viral replication and inflammatory responses through the activation of the MLC/p-MLC pathway [2][3] - This study is the first to elucidate the spreading mechanism of NDV infection and its contribution to systemic tissue damage, providing a new perspective on the disease's pathogenesis [2][3] Group 2: Research Background and Implications - The research originated from observations under a microscope, where it was noted that NDV infection damages tight junction barriers, facilitating the migration and spread of infected cells [3] - Unlike previous studies focused on vaccine prevention, the team explored the virus's own spreading mechanisms, aiming for a more fundamental solution to the problem [3] - The findings explain the molecular basis for the pathogenic differences between strong and weak NDV strains, offering potential targets for vaccine development [3] Group 3: Previous Achievements and Future Directions - Liu Xiufan's team has been dedicated to the epidemiology, prevention, and pathogenic mechanism research of NDV, successfully developing a vaccine that significantly controlled the disease in China [4] - The team has published multiple papers in PLOS Pathogens since 2024, detailing mechanisms of NDV-induced apoptosis in tumor cells and the virus's hijacking of host protein translation systems [4] - These series of studies provide important theoretical support for the design and development of effective oncolytic drugs [4]

图为国际原子能机构第30届聚变能大会上展出的新一代人造太阳"中国环流三号"的模型 樊巍/摄 新一代人造太阳"中国环流三号"装置（图片来源：中核集团） 来源：环球时报-环球网 【环球时报-环球网报道 记者 樊巍】"核聚变想要实现商业化发电需要经历六个阶段，目前我们正处于 第三个阶段。"在10月14日于成都举行的2025世界聚变能源集团第2次部长级会议暨国际原子能机构第30 届聚变能大会开幕式上，中核集团核工业西南物理研究院院长助理、聚变科学所所长钟武律在接受《环 球时报》记者采访时介绍称，实现核聚变能最终的商业化运用，需要经历原理探索、规模实验、燃烧实 验、实验堆、示范堆、商用堆六个阶段，目前中国已走到了燃烧实验阶段。"目前我们燃烧等离子体的 参数条件已经具备了。" 在本次两大核聚变能国际会议，中国何时可以实现核聚变商业化发电是各国媒体关注的焦点。在会场展 出的新一代人造太阳"中国环流三号"的模型前，核工业西南物理研究院的专家以开放的姿态向各国来宾 介绍中国聚变能技术研发的进展。 "根据我国的核聚变发展路线规划，将在2050年前后建成实现可以商用的核聚变发电，这个时间也和其 他国家预计时间相近，但我们正在努力让 ...

来源：重庆发布 近日，重庆南川区合溪镇发现一处 次生淋滤型石膏溶洞 洞内石膏晶体规模庞大 形态多样，在国内均属罕见 ▲南川发现国内罕见次生淋滤型石膏溶洞。唐湛 甘昊旻 摄 洞内千姿百态的洞穴景观令人目不暇接 "这个洞里石膏种类很多，包含了针状、树状、卷状等，在全国来说都是很罕见的。"经过实地考察后， 重庆市地矿局川东南地质大队地调院院长任廷聪介绍。 目前最常见的石膏洞属于常规沉积型石膏，它们就像古代海水蒸发晒盐一样，是直接结晶，形成较为简 单，形态也比较单一。 其中最引人注目的是形态各异的石膏晶体群 经初步估算 洞内原生石膏洞道将近3公里 且晶体结构完整、造型精美， 几乎涵盖了所有石膏形态 小布丁带你看 但受特殊地质构造影响，这个洞穴的石膏形成机制与常规沉积型石膏存在显著差异，属于次生淋滤型石 膏。石膏本身是硫酸钙，此处经过后期地壳的抬升，在地表水的渗漏下，这些硫酸钙重新从岩层的层面 渗漏出来，重新结晶，形成了次生淋滤型石膏。 ▲洞里形态各异的石膏晶体群。 次生淋滤型石膏是地下水亿万年持续渗滤的产物，就像钟乳石的形成过程，形成条件更加苛刻，但却能 造就"石膏花"等千姿百态的晶体形态。目前洞内不同形态石膏形成的 ...

来源：环球网 【环球网财经综合报道】据路透社等外媒报道，国际货币基金组织（IMF）总裁克里斯塔莉娜·格奥尔 基耶娃近日表示，全球正面临由人工智能（AI）驱动的快速技术革命，但各国在监管和伦理框架方面 准备不足，呼吁民间社会团体积极发声，推动相关讨论。 （图片来源：路透社） 在出席国际货币基金组织和世界银行年会期间，格奥尔基耶娃与民间社会团体交流时称，当前AI技术 革命主要由发达国家主导，其中美国处于领先地位，部分新兴市场也具备一定竞争力，但大多数发展中 国家仍远远落后，难以充分把握这一技术变革的机遇。 她强调，IMF担忧发达国家与发展中国家在AI准备度上的差距持续扩大，进一步加剧全球技术鸿沟，使 低收入国家更难追赶。此前，格奥尔基耶娃也曾警告，市场对AI的过高预期已推动相关金融资产估值 接近25年前互联网泡沫时期的水平，这可能对全球经济稳定构成风险，尤其是对发展中国家影响更为显 著。 格奥尔基耶娃表示，IMF正敦促发展中国家和新兴市场优先推进数字基础设施建设，并加强数字技能培 训，以提升应对AI变革的能力。她还透露，IMF已开发了一套"AI准备度指数"，从基础设施、劳动力与 技能、创新能力，以及监管与伦理四个 ...

来源：川观新闻 川观新闻记者 高杲 10月13日，光医学健康创新平台在成都正式启动，该平台由国家超算成都中心、脑全康光谱（成都）人 工智能科技有限公司等机构共同发起，旨在构建一个开放、协同的创新生态，推动光医学健康产业发 展。 活动现场，脑全康还和成都中医药大学国医馆、中国电信成都分公司等达成全面合作，将搭建集"算力 支撑—技术研发—临床应用—市场保障—标准规范"于一体的完整产业闭环，推动光医学技术、人工智 能大模型技术等新技术与健康指数、算力底座等交叉融合。 "光医学健康市场是巨大的蓝海市场，需要科技创新助力赋能，提供精准化、智能化解决方案。"脑全康 董事长张鹏说，下一步，平台将围绕三个方向开展工作：深化技术多元化场景的应用验证与落地，让创 新成果惠及更广泛的用户群体；通过国际合作，推动本土创新技术与产品的国际化交流；联合超算中 心、高校及医疗机构，推动光医疗健康行业应用标准的建立与完善。 活动现场 其中，国家超算成都中心提供强大算力支撑，重点解决传统光疗技术中数据处理难、模型训练慢、模型 性能弱等痛点问题。脑全康负责平台运营，构建开放、协同的创新生态，加速科研成果向临床应用尽 早、尽快转化。 ...